García-Puga, Mikel <br/><br/>
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin.  [electronic resource] 

 -  Aging  04 2020 
 - 6260-6275 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-4589 
<br/><br/><label>Standard No.: </label>10.18632/aging.103022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Energy Metabolism--drug effects<br/>Female<br/>Fibroblasts--metabolism<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Leukocytes, Mononuclear--metabolism<br/>Male<br/>Metformin--administration & dosage<br/>Mitochondria--metabolism<br/>Mitochondrial Diseases--drug therapy<br/>Myotonic Dystrophy--blood<br/>Oxidative Phosphorylation--drug effects<br/>Oxygen Consumption--drug effects<br/>Reactive Oxygen Species--analysis<br/>Treatment Outcome